Clinical Trials

A Phase II/III Study to Evaluate the Efficacy and Safety of Unesbulin in Unresectable or Metastatic, Relapsed or Refractory Leiomyosarcoma (SUNRISE LMS)

Link : https://wwww.clinicaltrials.gov/ct2/show/NCT05269355
Status : CLOSED
Population : LMS (fever than 4 lines of prior treatment)
Description : DTIC + unesbulin/placebo
PI : A. Salawu
Centers Opened : PMH
Phase : II/III
IIST/Pharma : Pharma